The peptide synthesis market is projected to reach over USD 1,066.7 million by 2032, reflecting robust growth driven by advances in peptide therapeutics and the…
Bioduro has announced the launch of a dedicated peptide business unit, marking a strategic expansion in their peptide research capabilities. This new unit is designed…
The field of peptide therapeutics continues to expand rapidly, with recent breakthroughs in peptide drugs highlighting the potential of these molecules in modern medicine. Advances…
The first quarter of 2025 has brought exciting developments in the peptide industry, with numerous breakthroughs in therapeutic peptides and drug development. This peptide news…
Biogen and Dayra Therapeutics have announced a strategic collaboration focused on developing macrocyclic peptides for next-generation peptide therapeutics. This partnership aims to leverage Dayra’s expertise…